# OnCo record fx-111 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/fx-111/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "fx-111" ;
  schema:name "FX-111"@en ;
  schema:description "FX-111 is an experimental protein degrader from Flare Therapeutics, in phase 1 trials for metastatic castration-resistant prostate cancer."@en ;
  schema:url <https://onco.cc/drugs/fx-111/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.flaretx.com/pipeline/fx-111/>, <https://clinicaltrials.gov/study/NCT07719361> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Degrader (the company describes its molecules as small molecules)" ;
  onco:cancers <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:targets <https://onco.cc/targets/androgen-receptor/> ;
  onco:companies <https://onco.cc/companies/flare-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct07719361/> .